Stock GLAND GLAND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Gland Pharma Limited Bombay S.E.

Equities

GLAND

INE068V01023

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 01:36:39 2024-04-25 am EDT 		5-day change 1st Jan Change
1,761 INR +0.20% Intraday chart for Gland Pharma Limited -0.16% -8.55%
Apr. 08 Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals CI
Apr. 08 Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection MT

Business Summary

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.

Number of employees: 4,585

Sales per Business

INR in Million2022Weight2023Weight Delta
Generic Injectibles
100.0 %
44,007 100.0 % 36,246 100.0 % -17.64%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
57.7 %
23,327 53.0 % 20,910 57.7 % -10.36%
Rest of World
19.0 %
8,481 19.3 % 6,893 19.0 % -18.73%
India
15.3 %
8,801 20.0 % 5,548 15.3 % -36.96%
Europe
5.2 %
2,398 5.4 % 1,871 5.2 % -21.97%
Canada
2.2 %
829 1.9 % 795 2.2 % -4.14%
Australia
0.6 %
171 0.4 % 218 0.6 % +27.72%
New Zealand
0.0 %
-- 11 0.0 % -

Managers

Managers TitleAgeSince
Srinivas Sadu CEO
 Chief Executive Officer 55 99-12-31
Ravi Shekhar Mitra DFI
 Director of Finance/CFO - 19-09-29
C. S. Venkatesan CTO
 Chief Tech/Sci/R&D Officer - 97-12-31
Pallerlamudi Sampath Kumar CMP
 Compliance Officer - 10-11-30
Surapanini Sridevi CTO
 Chief Tech/Sci/R&D Officer - 01-12-31
Prakash Vithal Baliga COO
 Chief Operating Officer - 15-12-31
Manish Bharadwaj HRO
 Human Resources Officer - -
Rong Wu AUD
 Comptroller/Controller/Auditor - -
Shilpi Sahay PRN
 Corporate Officer/Principal - 13-12-31
Ashish Adhikari PRN
 Corporate Officer/Principal - 19-08-11

Members of the board

Members of the board TitleAgeSince
Fang Yao BRD
 Director/Board Member 54 22-03-09
Srinivas Sadu CEO
 Chief Executive Officer 55 99-12-31
Yiu Kwan Lau CHM
 Chairman 69 19-06-09
Qi Yu Chen BRD
 Director/Board Member 52 17-10-02
Udo Johannes Vetter BRD
 Director/Board Member 69 18-02-06
Naina Lal Kidwai BRD
 Director/Board Member 67 21-05-16
Satyanaraynna Murthy Chavali BRD
 Director/Board Member 57 18-11-19
Essaji Goolam Vahanvati BRD
 Director/Board Member - 20-09-29
Jia Ai Zhang BRD
 Director/Board Member - 21-05-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 164,710,523 63,214,104 ( 38.38 %) 0 38.38 %

Shareholders

NameEquities%Valuation
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
57.86 %
95,293,894 57.86 % 2 105 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
6.193 %
10,201,139 6.193 % 225 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
5.531 %
9,109,390 5.531 % 201 M ₹
SBI Funds Management Ltd.
3.295 %
5,427,411 3.295 % 120 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
3.081 %
5,075,045 3.081 % 112 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.537 %
2,531,760 1.537 % 56 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management)
0.8250 %
1,358,874 0.8250 % 30 M ₹
Nomura Asset Management Singapore Ltd.
0.4723 %
777,943 0.4723 % 17 M ₹
Kotak Mahindra Asset Management Co. Ltd.
0.4296 %
707,631 0.4296 % 16 M ₹
Invesco Asset Management (India) Pvt Ltd.
0.3930 %
647,299 0.3930 % 14 M ₹

Company contact information

Gland Pharma Ltd.

TSIIC Phase: IV Plot No. 11 & 84

502307, Sangareddy

+91 84 5569 9999

http://www.glandpharma.com
address Gland Pharma Limited(GLAND)

Group companies

NameCategory and Sector
Gland Pharma International Pte Ltd.
Logo Gland Pharma International Pte Ltd.

Gland Pharma International Pte Ltd.

Pharmaceuticals: MajorHealth Technology

Gland Pharma International Pte Ltd. is a Singaporean company that manufactures liquid parenteral products. The private company is based in Singapore, Singapore and was founded in 2021.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Gland Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
1,757 INR
Average target price
1,845 INR
Spread / Average Target
+5.04%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.87% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.09% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 196B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GLAND Stock
  4. GLAND Stock
  5. Company Gland Pharma Limited